{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:53:36Z","timestamp":1794484416148,"version":"4.9.1"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,7]]},"abstract":"<jats:p>Metastatic neoplasms of unknown primary site pose a major challenge to patient management. As targeted therapies are now being tailored to neuroendocrine tumors (NETs) of different primary sites, identifying the origin of metastatic NETs has become increasingly important. Compared with more extensive efforts on metastatic adenocarcinomas of unknown primary, the literature on metastatic NETs (often to the liver) is relatively sparse and most studies are based on primary tumors. We sought to study metastatic well-differentiated NETs to the liver to identify markers that predict the site of origin. Eighty-five metastatic NETs to the liver were retrieved from the pathology archive. The primary sites were determined based on either pathologic review of the primary tumors (in most cases) or radiologic\/clinical findings. Immunohistochemical labeling for TTF1, CDX2, ISL1, NKX2.2, and PDX1 was performed on either tissue microarrays or whole sections. The primary sites of the NETs in the study cohort included: pancreas (35%), small intestine (32%), rectum (8%), stomach (2%), bile duct (1%), lung (9%), and unknown primary (12%). We found predominant expression of TTF1 in lung carcinoid (63%), CDX2 in small intestinal (89%) and ISL1 in pancreatic NETs (77%), respectively. NKX2.2 was mainly expressed in NETs of the digestive organs. PDX1 was detected in a small percentage of pancreatic, small intestinal and the single bile duct NET. There was no statistically significant association between tumor grade (World Health Organization G1 vs. G2) and the expression of any of the above markers. The 3-marker panel (TTF1, CDX2, and ISL1) had sensitivities of 81%, 89%, and 63%, specificities of 100%, 94%, and 100%, positive predictive values of 100%, 89%, and 100%, and negative predictive values of 84%, 94%, and 96% in separating metastatic NETs into 3 major primary sites: pancreas\/rectum, small intestine, and lung, respectively, with an overall accuracy of 82%. Furthermore, this panel predicted a primary site for 6 of the 10 NETs of unknown primary, which reduced the NETs of unknown primary from 12% to 5%. Thus, through immunohistochemical study of a large series of metastatic NETs to the liver, we have demonstrated the utility of a 3-marker panel for the identification of one or more potential primary sites of most metastatic NETs, which could provide practical guidance in patient management.<\/jats:p>","DOI":"10.1097\/pas.0000000000000876","type":"journal-article","created":{"date-parts":[[2017,5,12]],"date-time":"2017-05-12T13:02:23Z","timestamp":1494594143000},"page":"915-922","source":"Crossref","is-referenced-by-count":79,"title":["Immunohistochemical Characterization of the Origins of Metastatic Well-differentiated Neuroendocrine Tumors to the Liver"],"prefix":"10.1097","volume":"41","author":[{"given":"Zhaohai","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Pathology, Penn State Health Milton S. Hershey Medical Center, Hershey, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Klimstra","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph H.","family":"Hruban","sequence":"additional","affiliation":[{"name":"Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura H.","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230922","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2010.12.005","article-title":"The epidemiology of gastroenteropancreatic neuroendocrine tumors","volume":"40","author":"Lawrence","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"suppl 4","key":"R3-20230922","first-page":"iv1","article-title":"Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours","volume":"54","author":"Ramage","year":"2005","journal-title":"Gut"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1177\/030089161109700504","article-title":"Neuroendocrine tumors of unknown primary site: gold dust or misdiagnosed neoplasms?","volume":"97","author":"Catena","year":"2011","journal-title":"Tumori"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(63)90951-6","article-title":"The classification of carcinoid tumours","volume":"1","author":"Williams","year":"1963","journal-title":"Lancet"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/1097-0142(1971)28:4<990::AID-CNCR2820280424>3.0.CO;2-K","article-title":"Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases","volume":"28","author":"Soga","year":"1971","journal-title":"Cancer"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00129039-200206000-00001","article-title":"Thyroid transcription factor-1: a review","volume":"10","author":"Lau","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00125480-200403000-00004","article-title":"CDX-2, a new marker for adenocarcinoma of gastrointestinal origin","volume":"11","author":"Li","year":"2004","journal-title":"Adv Anat Pathol"},{"issue":"suppl 2","key":"R9-20230922","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1038\/modpathol.2010.166","article-title":"The origin of neuroendocrine tumors and the neural crest saga","volume":"24","author":"Rosai","year":"2011","journal-title":"Mod Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/modpathol.2012.34","article-title":"Value of Islet 1 and PAX8 in identifying metastatic neuroendocrine tumors of pancreatic origin","volume":"25","author":"Koo","year":"2012","journal-title":"Mod Pathol"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1097\/PAS.0000000000000435","article-title":"NKX6-1 is a novel immunohistochemical marker for pancreatic and duodenal neuroendocrine tumors","volume":"39","author":"Tseng","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/modpathol.3880044","article-title":"Thyroid transcription factor-1 is expressed in extrapulmonary small cell carcinomas but not in other extrapulmonary neuroendocrine tumors","volume":"13","author":"Agoff","year":"2000","journal-title":"Mod Pathol"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1053\/hupa.2001.28245","article-title":"Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors","volume":"32","author":"Cai","year":"2001","journal-title":"Hum Pathol"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00428-011-1118-6","article-title":"Hormonally defined pancreatic and duodenal neuroendocrine tumors differ in their transcription factor signatures: expression of ISL1, PDX1, NGN3, and CDX2","volume":"459","author":"Hermann","year":"2011","journal-title":"Virchows Arch"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.pai.0000210416.53493.0f","article-title":"Diagnostic value of CDX-2 and TTF-1 expressions in separating metastatic neuroendocrine neoplasms of unknown origin","volume":"15","author":"Lin","year":"2007","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/PAS.0b013e318158a397","article-title":"Islet 1 (Isl1) expression is a reliable marker for pancreatic endocrine tumors and their metastases","volume":"32","author":"Schmitt","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/PAS.0b013e31818d7d8b","article-title":"Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors","volume":"33","author":"Srivastava","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R18-20230922","first-page":"5","article-title":"Thyroid transcription factor-1: immunohistochemical evaluation in pulmonary neuroendocrine tumors","volume":"12","author":"Folpe","year":"1999","journal-title":"Mod Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00000478-200106000-00015","article-title":"Thyroid transcription factor-1 distinguishes metastatic pulmonary from well-differentiated neuroendocrine tumors of other sites","volume":"25","author":"Oliveira","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.5858\/2006-130-1522-EOTITF","article-title":"Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin","volume":"130","author":"Jaffee","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1309\/UKN6PVRKXHG422DA","article-title":"Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids","volume":"123","author":"Saqi","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/PAS.0b013e31821a0696","article-title":"Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification","volume":"35","author":"Yang","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/modpathol.2010.176","article-title":"PAX8 expression reliably distinguishes pancreatic well-differentiated neuroendocrine tumors from ileal and pulmonary well-differentiated neuroendocrine tumors and pancreatic acinar cell carcinoma","volume":"24","author":"Sangoi","year":"2011","journal-title":"Mod Pathol"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/096228029900800203","article-title":"The interpretation of diagnostic tests","volume":"8","author":"Shapiro","year":"1999","journal-title":"Stat Methods Med Res"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1196\/annals.1294.002","article-title":"The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification","volume":"1014","author":"Kloppel","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.semdp.2013.06.005","article-title":"Gastroenteropancreatic neuroendocrine neoplasms: historical context and current issues","volume":"30","author":"Yang","year":"2013","journal-title":"Semin Diagn Pathol"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"e435","DOI":"10.1016\/S1470-2045(15)00186-2","article-title":"Consensus on biomarkers for neuroendocrine tumour disease","volume":"16","author":"Oberg","year":"2015","journal-title":"Lancet Oncol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2559.2000.00890.x","article-title":"Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites","volume":"36","author":"Kaufmann","year":"2000","journal-title":"Histopathology"},{"key":"R29-20230922","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/01.MP.0000086073.92773.55","article-title":"Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays","volume":"16","author":"Moskaluk","year":"2003","journal-title":"Mod Pathol"},{"key":"R30-20230922","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s00428-004-1080-7","article-title":"CDX2 as a marker of intestinal EC-cells and related well-differentiated endocrine tumors","volume":"445","author":"La Rosa","year":"2004","journal-title":"Virchows Arch"},{"key":"R31-20230922","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/dvdy.10460","article-title":"Gene regulatory factors in pancreatic development","volume":"229","author":"Jensen","year":"2004","journal-title":"Dev Dyn"},{"key":"R32-20230922","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1677\/ERC-08-0204","article-title":"Sonic hedgehog and pancreatic-duodenal homeobox 1 expression distinguish between duodenal and pancreatic gastrinomas","volume":"16","author":"Fendrich","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"R33-20230922","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R34-20230922","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/PAS.0b013e3181da0a20","article-title":"PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors","volume":"34","author":"Long","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R35-20230922","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12022-014-9346-3","article-title":"Comparison of PAX6 and PAX8 as immunohistochemical markers for pancreatic neuroendocrine tumors","volume":"26","author":"Lai","year":"2015","journal-title":"Endocr Pathol"},{"key":"R36-20230922","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/PAI.0000000000000149","article-title":"The diagnostic utility of PAX8 for neuroendocrine tumors: an immunohistochemical reappraisal","volume":"24","author":"Liau","year":"2016","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R37-20230922","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12022-013-9264-9","article-title":"The immunohistochemical expression of islet 1 and PAX8 by rectal neuroendocrine tumors should be taken into account in the differential diagnosis of metastatic neuroendocrine tumors of unknown primary origin","volume":"24","author":"Koo","year":"2013","journal-title":"Endocr Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000478-201707000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:19:08Z","timestamp":1695421148000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201707000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000876","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]}}}